These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25663944)

  • 21. Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes.
    Jia MM; Liang ZJ; Chen Q; Zheng Y; Li LM; Cao XC
    Cancer Biol Med; 2014 Jun; 11(2):123-9. PubMed ID: 25009754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.
    Selz J; Stevens D; Jouanneau L; Labib A; Le Scodan R
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1123-32. PubMed ID: 22572073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
    Marinko T; Stanic K
    Radiol Oncol; 2018 Mar; 52(3):275-280. PubMed ID: 30210045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
    Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
    Front Oncol; 2022; 12():789198. PubMed ID: 35280719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.
    Shen H; Zhao L; Wang L; Liu X; Liu X; Liu J; Niu F; Lv S; Niu Y
    Tumour Biol; 2016 May; 37(5):6465-75. PubMed ID: 26631044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of post mastectomy radiotherapy among patients with T1/ T2 N1 disease: A retrospective cohort study.
    Vohra LM; Soomro R; Jabeen D; Ali N; Khan N
    Ann Med Surg (Lond); 2021 May; 65():102295. PubMed ID: 33948170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy.
    Wu SG; He ZY; Li Q; Li FY; Lin Q; Lin HX; Guan XX
    Breast; 2012 Oct; 21(5):657-61. PubMed ID: 22835918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Postmastectomy Radiotherapy on Locoregional Control and Disease-Free Survival in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Zhang Y; Zhang Y; Liu Z; Qin Z; Li Y; Zhao J; Ma X; Yang Q; Han N; Zeng X; Guo H; Zhang N
    J Oncol; 2021; 2021():6632635. PubMed ID: 33564308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
    Asaga S; Kinoshita T; Shiino S; Jimbo K; Takayama S
    Breast J; 2019 Jan; 25(1):26-33. PubMed ID: 30414218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database.
    Zhang J; Wang XX; Lian JY; Song CG
    Oncotarget; 2019 Aug; 10(50):5245-5252. PubMed ID: 31497253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy.
    Li C; Wang J; Mo M; Yuan J; Luo J; Jin K; Wang X; Yang Y; Ma J; Mei X; Yang Z; Yu X; Chen X; Guo X
    Cancer Manag Res; 2021; 13():3889-3899. PubMed ID: 34017195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
    Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
    Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes.
    Li Q; Wu S; Zhou J; Sun J; Li F; Lin Q; Guan X; Lin H; He Z
    Curr Oncol; 2014 Oct; 21(5):e685-90. PubMed ID: 25302039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
    Wang Q; Zhao J; Han X; Er P; Meng X; Shi J; Sun H; Zhu J; Zhu L; Wu S; Zhang W; Sun B
    Front Oncol; 2020; 10():892. PubMed ID: 32695661
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.
    Chen L; Zhang J; Chen J; Liu L; Liang L; Shangguan Z; Wang D
    Oncotarget; 2017 Jun; 8(26):42917-42925. PubMed ID: 28476034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which patients might benefit from postmastectomy radiotherapy in breast cancer patients with t1-2 tumor and 1-3 axillary lymph nodes metastasis?
    Kong M; Hong SE
    Cancer Res Treat; 2013 Jun; 45(2):103-11. PubMed ID: 23864843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.